CryoPort (CYRX) concentration risks

Cryoport's concentration profile combines a high-share geographic footprint with supplier and customer dependencies of differing scale. The Americas region accounts for approximately 74.5% of the business, a high-share structural concentration reflecting where Cryoport's cold-chain logistics infrastructure and customer base are centered rather than a reliance on any single counterparty. On the supply side, the company sources various component parts from independent manufacturers, some of which are sole sourced, a high-share dependency given the absence of disclosed alternative suppliers for those components. Separately, one customer within the Life Sciences Services reportable segment accounted for 10.2% of total revenue during the year, a low-share dependency that is modest relative to the other two exposures. Together, these describe a business whose revenue is geographically concentrated in the Americas as a structural feature of its footprint, whose manufacturing depends in part on sole-source component suppliers that could constrain production if disrupted, and whose customer base is otherwise diversified enough that even its single largest named customer represents only a low share of total revenue. The sole-source supplier relationship is the exposure most capable of an idiosyncratic disruption, since it lacks the redundancy that appears to exist elsewhere in the customer base.

For the engine’s reasoning on CYRX’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.